Alon Lazarus, Director, 10% Owner at Keros Therapeutics, Inc. (KROS), bought 1,502,295 shares at $16.00 ($1.9M) on 2020-04-13, disclosed to the SEC on 2020-04-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,382,295 | $0 | 0.0% |
| 2 | $16.00 | 120,000 | $1.9M | 100.0% |
| Total | $1.28 avg | 1,502,295 | $1.9M | 100% |